Biocept: Linda Rubinstein, Antonino Morales, Samuel Riccitelli

Biocept has appointed Linda Rubinstein and Antonino Morales to its board of directors, effective immediately. The company also named Samuel Riccitelli as chairman of the board, succeeding long-time chair David Hale and interim Chair Faye Wilson, both of whom remain directors.

Rubinstein has been a partner at FLG Partners, providing consulting services to life science and other companies such as Apexigen, ArmaGen, Five Prime, Kezar Life Sciences, Ingenuity Systems, iPierian, and True North. Previously, she was a Principal at RDJ Advisors, and served as vice president and CFO at Solexa. Morales is a CPA who has worked with leading organizations such as Citibank, Bank of America, Arthur Anderson, and Mazda North America. Morales was president and CEO of Apoyo Financiero, a California-based community developmen financial institution.

Riccitelli was appointed to Biocept's board in October 2020 and currently serves as an independent consultant to healthcare companies and as a director of OrthoPediatrics.